Idehen Charles Iyore
Idehen Charles Iyore has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Bot Yakubu Sunday
Department of Medical Laboratory Science, School of Allied Health Sciences, Kampala International University Western Campus, Bushenyi District, Uganda
1 shared publication - Deko Omar Mohamed
Department of Medical Laboratory Science, School of Allied Health Sciences, Kampala International University Western Campus, Bushenyi District, Uganda
1 shared publication - Glory Mbe Nja
Department of Public Health, School of Allied Health Sciences, Kampala International University Western Campus, Bushenyi District, Uganda
1 shared publication - Hani Mohamed Mohamud
Department of Medical Laboratory Science, School of Allied Health Sciences, Kampala International University Western Campus, Bushenyi District, Uganda
1 shared publication - Maria Ali Mudei
Department of Medical Laboratory Science, School of Allied Health Sciences, Kampala International University Western Campus, Bushenyi District, Uganda
1 shared publication - Michael Ben Okon
Biochemistry Bushenyi Western Region Kampala International University - Western Campus
1 shared publication
Latest Publications
- Open Access
- 13 October 2026
- Published by Springer Nature in Basic and Clinical Andrology
- Vol. 36 (1) , 28
Protective effects of naringenin and naringin against bisphenol A–induced male reproductive toxicity: mechanistic and preclinical evidence
Bisphenol A (BPA) has been associated with altered male reproductive hormones and semen endpoints in epidemiological studies and produces endocrine, oxidative, mitochondrial, apoptotic, and developmental injury in experimental models. This narrative review evaluates BPA-specific evidence for naringenin and naringin separately from supportive evidence in other reproductive stress models. It also distinguishes directly exposed F1 outcomes from transgenerational inheritance and links sperm endpoints to hormones, histology, and molecular measures. This narrative review synthesizes evidence published mainly between January 2019 through September 2026, while retaining older studies of direct mechanistic relevance. Evidence was identified through targeted searches of PubMed, Scopus-indexed sources, Google Scholar, and publisher databases and was organized by exposure timing, biological mechanism, model type, and reproductive endpoint. The strongest evidence for BPA-related male reproductive toxicity comes from convergent cellular and animal data supported by heterogeneous human observational studies. The strongest evidence for naringenin or naringin is preclinical and includes BPA-specific Sertoli-cell and rat models as well as related oxidative, metabolic, and phthalate stress models. Across the broader preclinical literature, the flavanones modify redox, mitochondrial, inflammatory, and steroidogenic endpoints, but differences in model, dose, route, and bioavailability prevent quantitative comparison. The evidence supports mechanistic research, not clinical supplementation, and exposure reduction remains the primary public-health approach.
- 13 October 2026
- Published by Springer Nature in Basic and Clinical Andrology
- Vol. 36 (1) , 28
Open AccessProtective effects of naringenin and naringin against bisphenol A–induced male reproductive toxicity: mechanistic and preclinical evidence
Bisphenol A (BPA) has been associated with altered male reproductive hormones and semen endpoints in epidemiological studies and produces endocrine, oxidative, mitochondrial, apoptotic, and developmental injury in experimental models. This narrative review evaluates BPA-specific evidence for naringenin and naringin separately from supportive evidence in other reproductive stress models. It also distinguishes directly exposed F1 outcomes from transgenerational inheritance and links sperm endpoints to hormones, histology, and molecular measures. This narrative review synthesizes evidence published mainly between January 2019 through September 2026, while retaining older studies of direct mechanistic relevance. Evidence was identified through targeted searches of PubMed, Scopus-indexed sources, Google Scholar, and publisher databases and was organized by exposure timing, biological mechanism, model type, and reproductive endpoint. The strongest evidence for BPA-related male reproductive toxicity comes from convergent cellular and animal data supported by heterogeneous human observational studies. The strongest evidence for naringenin or naringin is preclinical and includes BPA-specific Sertoli-cell and rat models as well as related oxidative, metabolic, and phthalate stress models. Across the broader preclinical literature, the flavanones modify redox, mitochondrial, inflammatory, and steroidogenic endpoints, but differences in model, dose, route, and bioavailability prevent quantitative comparison. The evidence supports mechanistic research, not clinical supplementation, and exposure reduction remains the primary public-health approach.
- Open Access
- 2 February 2026
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 26 (1)
Effects of aqueous aloe vera gel extract on acetaminophen-induced liver damage: a histomorphological, hematological and biochemical study in Albino rats
Background: Acetaminophen overdose is a leading cause of drug-induced acute liver damage, underscoring the urgent need for accessible hepatoprotective therapies. This study evaluated the hepatoprotective effects of Aqueous Aloe vera gel extract on acetaminophen-induced liver damage in adult male Albino Wistar rats. Methodology: Liver Damage was induced in Albino Wistar rats by oral administration of acetaminophen (750 mg/kg). The rats were divided into six groups: normal control, negative control, positive control (silymarin 50 mg/kg), and three treatment groups receiving Aloe vera gel extract at doses of 250 mg/kg, 500 mg/kg, and 1000 mg/kg. Body and liver weight, hematological, biochemical and oxidative stress parameters and liver histology were assessed after 7 days of treatment. Results: Treatment with Aloe vera gel extract demonstrated dose-dependent hepatoprotective, anti-inflammatory and antioxidant effects with the 1000 mg/kg dose exhibiting efficacy comparable to silymarin. Higher doses (1000 mg/kg) significantly increase both the body weight and weight of the liver ( p = 0.0265 and p = 0.0061); decreased the white blood cell count ( p = 0.0034) and also improved hematological parameters. The extract at 1000 mg/kg also enhanced antioxidant status by reducing MDA levels ( p < 0.0001) while increasing SOD ( p < 0.0001) and catalase activities. Histological examination also showed that higher doses of the aqueous Aloe vera gel extract restored liver histoarchitecture, with clearly defined nuclei and cell borders. Conclusion: This study demonstrates that the aqueous Aloe vera gel extract mitigates acetaminophen-induced hepatotoxicity through antioxidant, anti-inflammatory, and regenerative mechanisms. At 1000 mg/kg, it restored hepatic histoarchitecture, haematological homeostasis, normalized liver function biomarkers, and suppressed oxidative stress, rivalling silymarin in efficacy. The observed improvements in liver histology, haematological parameters, and antioxidant biomarkers indicate Aloe vera ’s therapeutic potential, likely mediated through its bioactive constituents with antioxidant and anti-inflammatory properties. Further research is recommended to understand its mechanism of action, long-term and potential clinical applications.
- 2 February 2026
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 26 (1)
Open AccessEffects of aqueous aloe vera gel extract on acetaminophen-induced liver damage: a histomorphological, hematological and biochemical study in Albino rats
Background: Acetaminophen overdose is a leading cause of drug-induced acute liver damage, underscoring the urgent need for accessible hepatoprotective therapies. This study evaluated the hepatoprotective effects of Aqueous Aloe vera gel extract on acetaminophen-induced liver damage in adult male Albino Wistar rats. Methodology: Liver Damage was induced in Albino Wistar rats by oral administration of acetaminophen (750 mg/kg). The rats were divided into six groups: normal control, negative control, positive control (silymarin 50 mg/kg), and three treatment groups receiving Aloe vera gel extract at doses of 250 mg/kg, 500 mg/kg, and 1000 mg/kg. Body and liver weight, hematological, biochemical and oxidative stress parameters and liver histology were assessed after 7 days of treatment. Results: Treatment with Aloe vera gel extract demonstrated dose-dependent hepatoprotective, anti-inflammatory and antioxidant effects with the 1000 mg/kg dose exhibiting efficacy comparable to silymarin. Higher doses (1000 mg/kg) significantly increase both the body weight and weight of the liver ( p = 0.0265 and p = 0.0061); decreased the white blood cell count ( p = 0.0034) and also improved hematological parameters. The extract at 1000 mg/kg also enhanced antioxidant status by reducing MDA levels ( p < 0.0001) while increasing SOD ( p < 0.0001) and catalase activities. Histological examination also showed that higher doses of the aqueous Aloe vera gel extract restored liver histoarchitecture, with clearly defined nuclei and cell borders. Conclusion: This study demonstrates that the aqueous Aloe vera gel extract mitigates acetaminophen-induced hepatotoxicity through antioxidant, anti-inflammatory, and regenerative mechanisms. At 1000 mg/kg, it restored hepatic histoarchitecture, haematological homeostasis, normalized liver function biomarkers, and suppressed oxidative stress, rivalling silymarin in efficacy. The observed improvements in liver histology, haematological parameters, and antioxidant biomarkers indicate Aloe vera ’s therapeutic potential, likely mediated through its bioactive constituents with antioxidant and anti-inflammatory properties. Further research is recommended to understand its mechanism of action, long-term and potential clinical applications.